Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Clear Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07077083
What this trial is testing

CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)ccRCC
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04535687
What this trial is testing

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1
Early research (Phase 1)Study completedNCT01497821
What this trial is testing

AMG 172 First in Human Study in Patients With Kidney Cancer

Who this might be right for
Renal Cell AdenocarcinomaClear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma+1 more
Amgen 37
Early research (Phase 1)Study completedNCT01331135
What this trial is testing

Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors

Who this might be right for
Ewing's SarcomaOsteosarcomaAstrocytoma+13 more
Emory University 18
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Not applicableStudy completedNCT05745142
What this trial is testing

Go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.

Who this might be right for
Carcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
Pfizer 376
Testing effectiveness (Phase 2)Study completedNCT03013335
What this trial is testing

Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen

Who this might be right for
Metastatic Renal Cell Carcinoma
UNICANCER 730
Testing effectiveness (Phase 2)Looking for participantsNCT07187778
What this trial is testing

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 10
Early research (Phase 1)Study completedNCT00085358
What this trial is testing

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Carcinosarcoma+10 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Looking for participantsNCT05155033
What this trial is testing

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Metastatic MelanomaAdvanced Locoregional MelanomaMetastatic Renal Cell Carcinoma+1 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT02101775
What this trial is testing

Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+9 more
National Cancer Institute (NCI) 124
Testing effectiveness (Phase 2)UnknownNCT04644432
What this trial is testing

Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaKidney NeoplasmUrologic Neoplasms+1 more
Herlev and Gentofte Hospital 30
Not applicableStudy completedNCT01080521
What this trial is testing

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

Who this might be right for
Cognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more
Gynecologic Oncology Group 247
Early research (Phase 1)Study completedNCT01472081
What this trial is testing

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

Who this might be right for
Renal Cell CarcinomaClear-cell Metastatic Renal Cell Carcinoma
Bristol-Myers Squibb 194
Post-approval studies (Phase 4)Ended earlyNCT00930345
What this trial is testing

Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07488572
What this trial is testing

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT02917772
What this trial is testing

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 200
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Large-scale testing (Phase 3)Study completedNCT00006011
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+3 more
Gynecologic Oncology Group 659
Next Page